PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $46,000 | -11.5% | 16,026 | -6.6% | 0.00% | – |
| Q4 2021 | $52,000 | -58.1% | 17,154 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $124,000 | -24.4% | 17,668 | -1.3% | 0.00% | 0.0% |
| Q2 2021 | $164,000 | -6.3% | 17,903 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $175,000 | -4.9% | 17,982 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $184,000 | 0.0% | 17,934 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $184,000 | -5.6% | 18,264 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $195,000 | +26.6% | 18,680 | +2.6% | 0.00% | 0.0% |
| Q1 2020 | $154,000 | -8.9% | 18,210 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $169,000 | -19.1% | 19,262 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $209,000 | -16.1% | 19,424 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $249,000 | -65.4% | 19,559 | +5.3% | 0.00% | -66.7% |
| Q1 2019 | $720,000 | +84.6% | 18,569 | -3.1% | 0.00% | +50.0% |
| Q4 2018 | $390,000 | -56.0% | 19,172 | -0.8% | 0.00% | -33.3% |
| Q3 2018 | $886,000 | -21.0% | 19,319 | +1.8% | 0.00% | -25.0% |
| Q2 2018 | $1,122,000 | -11.6% | 18,971 | +1.8% | 0.00% | 0.0% |
| Q1 2018 | $1,269,000 | -33.7% | 18,644 | -3.7% | 0.00% | -33.3% |
| Q4 2017 | $1,913,000 | -17.1% | 19,353 | +0.5% | 0.01% | -25.0% |
| Q3 2017 | $2,307,000 | +48.1% | 19,262 | +8.1% | 0.01% | +33.3% |
| Q2 2017 | $1,558,000 | +147.3% | 17,821 | +5.3% | 0.01% | +200.0% |
| Q1 2017 | $630,000 | +44.5% | 16,931 | +19.2% | 0.00% | 0.0% |
| Q4 2016 | $436,000 | -100.0% | 14,198 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $954,457,000 | +125.4% | 14,235 | +0.1% | 0.00% | +100.0% |
| Q2 2016 | $423,435,000 | +2128.6% | 14,214 | +2110.6% | 0.00% | – |
| Q1 2016 | $19,000,000 | -62.0% | 643 | +1.7% | 0.00% | – |
| Q4 2015 | $50,000,000 | +111011.1% | 632 | +4.1% | 0.00% | – |
| Q3 2015 | $45,000 | -99.9% | 607 | +10.2% | 0.00% | – |
| Q2 2015 | $64,329,000 | -98.1% | 551 | -96.2% | 0.00% | -100.0% |
| Q1 2015 | $3,446,734,000 | +24.7% | 14,598 | 0.0% | 0.01% | +16.7% |
| Q4 2014 | $2,762,963,000 | -23.7% | 14,598 | -3.8% | 0.01% | -25.0% |
| Q3 2014 | $3,620,538,000 | +261.2% | 15,176 | -0.1% | 0.02% | +300.0% |
| Q2 2014 | $1,002,342,000 | -36.1% | 15,187 | +0.8% | 0.00% | -42.9% |
| Q1 2014 | $1,568,453,000 | +3.1% | 15,061 | +2.5% | 0.01% | 0.0% |
| Q4 2013 | $1,521,787,000 | +91.0% | 14,699 | -1.0% | 0.01% | +75.0% |
| Q3 2013 | $796,636,000 | – | 14,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |